| Literature DB >> 34335869 |
Geoffrey K Seidel1, Salma Al Jamal2, Eric Weidert3, Frederick Carington3, Michael T Andary3, Scott R Millis4, Brian G Loder5.
Abstract
Background The relationship between tarsal tunnel syndrome (TTS), electrodiagnostic (Edx) findings, and surgical outcome is unknown. Analysis of TTS surgical release outcome patient satisfaction and comparison to Edx nerve conduction studies (NCSs) is important to improve outcome prediction when deciding who would benefit from TTS release. Methods Retrospective study of 90 patients over 7 years that had tarsal tunnel (TT) release surgery with outcome rating and preoperative tibial NCS. Overall, 64 patients met study inclusion criteria with enough NCS data to be classified into one of the following three groups: (1) probable TTS, (2) peripheral polyneuropathy, or (3) normal. Most patients had preoperative clinical provocative testing including diagnostic tibial nerve injection, tibial Phalen's sign, and/or Tinel's sign and complaints of plantar tibial neuropathic symptoms. Outcome measure was percentage of patient improvement report at surgical follow-up visit. Results Patient-reported improvement was 92% in the probable TTS group ( n = 41) and 77% of the non-TTS group ( n = 23). Multivariate modeling revealed that three out of eight variables predicted improvement from surgical release, NCS consistent with TTS ( p = 0.04), neuropathic symptoms ( p = 0.045), and absent Phalen's test ( p = 0.001). The R 2 was 0.21 which is a robust result for this outcome measurement process. Conclusion The best predictors of improvement in patients with TTS release were found in patients that had preoperative Edx evidence of tibial neuropathy in the TT and tibial nerve plantar symptoms. Determining what factors predict surgical outcome will require prospective evaluation and evaluation of patients with other nonsurgical modalities. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).Entities:
Keywords: lateral plantar nerve; medial plantar nerve; nerve conduction; outcome modeling; surgery; tarsal tunnel syndrome
Year: 2021 PMID: 34335869 PMCID: PMC8315987 DOI: 10.1055/s-0041-1731747
Source DB: PubMed Journal: J Brachial Plex Peripher Nerve Inj ISSN: 1749-7221
Fig. 1Foot plantar dissection with forceps holding medial plantar nerve and arrow marking lateral plantar nerve. Nerve stimulation performed at arrow location.
Fig. 2Cathode (black) stimulation of medial plantar MNAP just proximal to the metatarsal heads between the first and second metatarsals with E1 (black) 14-cm proximal across the tarsal tunnel on the tibial nerve. Lateral plantar stimulation is achieved by moving the cathode to the mark between the fourth and fifth metatarsals with the same E1 distance and setup. MNAP, mixed nerve action potential.
Improvement outcome regression modeling group rating, selected nerve conduction study parameters, and clinical examination observations
| Robust SE | ||||||
|---|---|---|---|---|---|---|
| Improvement | Coefficient |
|
| [95% CI] | ||
| ProbTTS | 1.687 | 0.820 | 2.06 | 0.040 | 0.078 | 3.296 |
| MPPL | 0.378 | 0.224 | 1.69 | 0.092 | −0.061 | 0.817 |
| LPPL | −0.276 | 0.246 | −1.12 | 0.262 | −0.760 | 0.206 |
| TMDL | −0.413 | 0.300 | −1.38 | 0.169 | −1.001 | 0.175 |
| NBlock | 1.248 | 0.689 | 1.81 | 0.070 | −0.102 | 2.599 |
| Tinel's sign | 0.061 | 1.491 | 0.04 | 0.967 | −2.862 | 2.985 |
| Phalen's sign | −16.06 | 0.718 | −22.3 | 0.001 | −17.47 | −14.65 |
| NSymp | 1.550 | 0.773 | 2.00 | 0.045 | 0.034 | 3.067 |
| Constant | 16.51 | 2.561 | 6.45 | 0.00 | 11.499 | 21.538 |
Abbreviations: CI, confidence interval; LPPL, lateral plantar peak latency; MPPL, medial plantar peak latency; NBlock, tibial nerve block; NSymp, tibial plantar neurogenic symptoms; Phalen's sign, tibial Phalen's result; ProbTTS, electrodiagnostic probable tarsal tunnel syndrome; SE, standard error; Tinel's sign, tibial nerve Tinel's result; TMDL, tibial motor distal latency.
Patient descriptive demographics and preoperative clinical examination observations
| Variable | Patients |
|---|---|
|
Female (
| 52/64, 81.3 |
| Age, mean years ( ± SD) | 50.9, 13.6 |
| BMI, mean kg/m 2 ( ± SD) | 30.2, 6.8 |
|
DM type 2 (
| 8/64, 12.5 |
| Surgical side | |
|
Right (
| 32/64, 50 |
|
Left (
| 32/64, 50 |
|
Positive nerve block (
| 40/63, 63.5 |
|
Positive Tinel's sign (
| 50/52, 96.2 |
|
Positive Phalen's sign (
| 33/40, 82.5 |
|
Nerve symptoms (
| 59/63, 93.7 |
Abbreviations: BMI, body mass index; DM, diabetes mellitus; SD, standard deviation.
Stratified groups based on age, BMI and percentage of improvement patient rating, delta motor– and delta sensory–derived variables following surgery
|
| Age in y (mean, SD) | BMI in kg/m 2 (mean, SD) | % Improve (mean, SD) | DMT in ms (mean, SD) | DSN in ms (mean, SD) | |
|---|---|---|---|---|---|---|
| TTS | 4 | 49.5, 18.4 | 26.9, 5.1 | 93.8, 12.5 | 1.9, 0.2 | 7.9, 5.4 |
| PTT | 37 | 51.2, 11.9 | 30.7, 7.3 | 92.0, 17.9 | 1.0, 0.9 | 9.3, 5.3 |
| PPN | 14 | 58.6, 10.2 | 32.3, 5.3 | 82.5, 28.7 | 0.5, 0.7 | −1.0, 4.1 |
| Norm | 9 | 38.3, 15.4 | 26.0, 6.0 | 67.8, 36.7 | −0.1, 0.9 | 7.3, 6.4 |
| Total | 64 | 50.9, 13.6 | 30.2, 6.8 | 86.6, 24.6 | 0.8, 1.0 | 6.7, 6.6 |
Abbreviations: BMI, body mass index; DMT, tibial motor minus fibular motor distal latency; DSN, sural sensory amplitude minus (medial + lateral plantar amplitudes)/2; Norm, electrodiagnostic normal; PPN, electrodiagnostic peripheral polyneuropathy; PTT, electrodiagnostic possible tarsal tunnel syndrome; SD, standard deviation; TTS, electrodiagnostic tarsal tunnel syndrome.
Nerve conduction study data stratified by group designation (TT, PTT, PPN, and Norm)
|
TT
|
PTT
|
PPN
|
Norm
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Mean/SD | Min/Max | NR (%) |
| Mean/SD | Min/Max | NR (%) |
| Mean/SD | Min/Max | NR (%) |
| Mean/SD | Min/Max | NR (%) | |
| Sural | ||||||||||||||||
| PL (ms) | 3 | 3.9/0.1 | 3.8/4 | 0 | 35 | 3.8/0.5 | 2.5/5.2 | 0 | 1 | 4.5 | 93 | 9 | 3.7/0.3 | 3.3/4.1 | 0 | |
| Amp (uV) | 3 | 10.5/1.5 | 9.0/12.0 | 0 | 35 | 10.6/4.6 | 5.0/22.0 | 0 | 1 | 5.6 | 93 | 9 | 15.7/6.5 | 10.0/25.7 | 0 | |
| Superficial fibular | ||||||||||||||||
| PL (ms) | 1 | 3.8 | 0 | 5 | 3.7/0.1 | 3.5/3.8 | 0 | 5 | 100 | 1 | 3.6 | 0 | ||||
| Amp (uV) | 1 | 14 | 0 | 5 | 8.9/4.4 | 6.0/16.7 | 0 | 5 | 100 | 1 | 10.6 | 0 | ||||
| Fibular motor | ||||||||||||||||
| DL (ms) | 4 | 5.0/0.5 | 4.3/5.4 | 0 | 31 | 4.8/0.6 | 3.6/5.9 | 0 | 11 | 4.9/0.6 | 3.8/6.0 | 20 | 8 | 5.0/0.8 | 4/6.2 | 13 |
| Amp (mV) | 4 | 2.7/0.8 | 1.6/0.5 | 0 | 31 | 4.3/1.5 | 1.4/7.0 | 0 | 11 | 3.8/2.4 | 1.6/10.1 | 20 | 8 | 4.9/2.0 | 1.9/7.7 | 13 |
| CV (m/s) | 4 | 46/2.9 | 43/9 | 0 | 31 | 46/4.2 | 37.0/60.0 | 0 | 11 | 46/5.3 | 39/56 | 20 | 8 | 48/4.7 | 40/53 | 13 |
| Med plantar | ||||||||||||||||
| PL (ms) | 4 | 100 | 8 | 6.2/1.3 | 3.9/8.4 | 78 | 3 | 5.9/0.5 | 5.3/6.3 | 79 | 9 | 3.7/0.4 | 3.3/4.5 | 0 | ||
| Amp (uV) | 4 | 100 | 8 | 6.1/3.5 | 3.3/12.3 | 78 | 3 | 8.9/5.1 | 5.7/14.8 | 79 | 9 | 7.8/3.2 | 3.0/12.1 | 0 | ||
| Lat plantar | ||||||||||||||||
| PL (ms) | 4 | 100 | 4 | 5.4/1.1 | 4.1/6.7 | 89 | 1 | 4.9 | 93 | 8 | 4.0/1.0 | 3.4/6.3 | 13 | |||
| Amp (uV) | 4 | 100 | 4 | 5.3/0.2 | 5.0/5.5 | 89 | 1 | 12.3 | 93 | 8 | 9.1/3.0 | 4.0/12.3 | 13 | |||
| Tibial motor | ||||||||||||||||
| DL (ms) | 4 | 6.9/0.4 | 6.4/7.3 | 0 | 37 | 5.6/1.0 | 3.3/7.8 | 0 | 12 | 5.5/0.9 | 4.5/7.4 | 14 | 9 | 4.8/0.8 | 4.1/6.4 | 0 |
| Amp (mV) | 4 | 10.4/2.6 | 6.7/12.5 | 0 | 37 | 7.6/3.6 | 0.6/15.4 | 0 | 12 | 6.6/4.5 | 1.1/14.8 | 14 | 9 | 7.8/2.8 | 2.9/11.3 | 0 |
| CV (m/s) | 4 | 45/1.0 | 43/45 | 0 | 35 | 47/5.9 | 38/59 | 2/5.0 | 12 | 44/4.6 | 35/49 | 14 | 9 | 48/4.6 | 41/55 | 0 |
Abbreviations: Amp, amplitude; CV, conduction velocity; DL, distal onset latency; Max, maximum; Min, minimum; Norm, normal; NR, not reported; PL, peak latency; PPN, peripheral polyneuropathy; PTT, possible tarsal tunnel; SD, standard deviation; TT, tarsal tunnel.
Note: Group numbers ( N ), Mean, Range descriptive statistics are provided for each nerve, as well as absent response (NR).
Improvement outcome regression modeling group rating (ProbTTS), nerve symptoms, and nerve conduction study data
| Robust SE | ||||||
|---|---|---|---|---|---|---|
| Improvement | Coefficient |
|
| [95% CI] | ||
| ProbTTS | 1.255 | 0.483 | 2.60 | 0.009 | 0.308 | 2.202 |
| Delta motor | 0.236 | 0.162 | 1.46 | 0.145 | −0.081 | 0.555 |
| NSymp | 1.763 | 0.581 | 3.03 | 0.002 | 0.624 | 2.903 |
| MPPL | 0.180 | 0.149 | 1.21 | 0.228 | −0.111 | 0.473 |
| LPPL | −0.187 | 0.198 | −0.94 | 0.346 | −0.577 | 0.202 |
| Delta sensory | −0.015 | 0.053 | −0.29 | 0.768 | −0.204 | 0.088 |
| Constant | −0.205 | 0.708 | −0.29 | 0.771 | −1.593 | 1.182 |
Abbreviations: CI, confidence interval; Delta Motor, tibial motor minus fibular motor distal latency; Delta sensory, sural sensory amplitude minus (medial + lateral plantar amplitudes)/2; LPPL, lateral plantar peak latency; MPPL, medial plantar peak latency; NSymp, tibial plantar neurogenic symptoms; ProbTTS, electrodiagnostic probable tarsal tunnel syndrome; SE, standard error.